Association of Programmed Death 1 Protein Ligand (PD-L1) Expression With Prognosis in Merkel Cell Carcinoma

Association of Programmed Death 1 Protein Ligand (PD-L1) Expression With Prognosis in Merkel Cell Carcinoma

Background: Merkel cell carcinoma (MCC) is a rare neuroendocrine skin cancer. Prior to the advent of immunotherapy, treatment options were limited. In our study, we evaluate the impact of tumor cell PD-L1 expression and tumor immune microenvironment on survival in MCC patients who were not treated w...

Full description

Bibliographic Details
Main Authors: Glenn J. Hanna, Alec J. Kacew, Anusha R. Tanguturi, Hans J. Grote, Victoria Vergara, Beatrice Brunkhorst, Guilherme Rabinowits, Manisha Thakuria, Nicole R. LeBoeuf, Christian Ihling, James A. DeCaprio, Jochen H. Lorch
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-06-01
Series:Frontiers in Medicine
Subjects:
PD-L1
merkel cell carcinoma
cancer
neuroendocrine carcinoma
prognostic biomarkers
merkel cell polyomavirus
Online Access:https://www.frontiersin.org/article/10.3389/fmed.2020.00198/full

Internet

https://www.frontiersin.org/article/10.3389/fmed.2020.00198/full

Similar Items